Business Standard

Covid-19: $30 bn needed to develop tests, treatments, vaccines, says WHO

The WHO is working with a large coalition of drug-development, funding and distribution organisations under what it calls the ACT-Accelerator Hub

pharmacy, drugs, medicine, pharma companies, pharmaceuticals, vaccine, coronavirus, covid, testing
Premium

The initiative is intended to develop and deliver 500 million Covid-19 tests and 245 million courses of new treatment for the disease

Reuters
A World Health Organization-led coalition fighting the Covid-19 pandemic is asking government and private sector donors to help raise $31.3 billion in the next 12 months to develop and deliver tests, treatments and vaccines for the disease.

Renewing its call on Friday for global collaboration against the pandemic, it said $3.4 billion had been contributed for the coalition to date, leaving a funding gap of $27.9 billion. Of that, $13.7 billion was "urgently needed".
The WHO is working with a large coalition of drug-development, funding and distribution

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in